期刊
ONCOIMMUNOLOGY
卷 1, 期 7, 页码 1181-1182出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/onci.20639
关键词
T-reg cells; immunotherapy; interleukin-2; tumor
Augmented numbers of regulatory T cells contribute to the overall immunosuppression in tumor patients. Interleukin-2 has been widely used in the clinics in anticancer therapy, yet evidence has accumulated that the major drawback, limiting clinical efficacy, is the expansion of regulatory T cells, which aggravates immunosuppression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据